DE3923638C2 - Salze aus Ranitidin und einem Komplex von Bismut mit einer Carbonsäure, Verfahren zu deren Herstellung und diese Salze enthaltende pharmazeutische Präparate - Google Patents
Salze aus Ranitidin und einem Komplex von Bismut mit einer Carbonsäure, Verfahren zu deren Herstellung und diese Salze enthaltende pharmazeutische PräparateInfo
- Publication number
- DE3923638C2 DE3923638C2 DE3923638A DE3923638A DE3923638C2 DE 3923638 C2 DE3923638 C2 DE 3923638C2 DE 3923638 A DE3923638 A DE 3923638A DE 3923638 A DE3923638 A DE 3923638A DE 3923638 C2 DE3923638 C2 DE 3923638C2
- Authority
- DE
- Germany
- Prior art keywords
- bismuth
- methyl
- complex
- ranitidine
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888817098A GB8817098D0 (en) | 1988-07-18 | 1988-07-18 | Chemical compounds |
GB898904686A GB8904686D0 (en) | 1989-03-01 | 1989-03-01 | Chemical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3923638A1 DE3923638A1 (de) | 1990-03-01 |
DE3923638C2 true DE3923638C2 (de) | 1995-11-23 |
Family
ID=26294175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3923638A Expired - Fee Related DE3923638C2 (de) | 1988-07-18 | 1989-07-17 | Salze aus Ranitidin und einem Komplex von Bismut mit einer Carbonsäure, Verfahren zu deren Herstellung und diese Salze enthaltende pharmazeutische Präparate |
Country Status (35)
Country | Link |
---|---|
US (1) | US5008256A (da) |
JP (1) | JP2523185B2 (da) |
KR (1) | KR0122598B1 (da) |
CN (1) | CN1022626C (da) |
AT (1) | AT398200B (da) |
AU (1) | AU632052B2 (da) |
BE (1) | BE1003254A5 (da) |
CA (1) | CA1332610C (da) |
CH (1) | CH679582A5 (da) |
CY (1) | CY1650A (da) |
DE (1) | DE3923638C2 (da) |
DK (1) | DK168381B1 (da) |
EG (1) | EG19368A (da) |
ES (1) | ES2014175A6 (da) |
FI (1) | FI90538C (da) |
FR (1) | FR2634122B1 (da) |
GB (1) | GB2220937B (da) |
GR (1) | GR1000431B (da) |
HK (1) | HK61392A (da) |
HU (2) | HU206104B (da) |
IE (1) | IE61076B1 (da) |
IL (1) | IL91005A (da) |
IT (1) | IT1231481B (da) |
LU (2) | LU88722I2 (da) |
MX (1) | MX174145B (da) |
MY (1) | MY104055A (da) |
NL (2) | NL192604C (da) |
NO (2) | NO176319C (da) |
NZ (1) | NZ229958A (da) |
PL (1) | PL162391B1 (da) |
PT (1) | PT91188B (da) |
SE (1) | SE468715B (da) |
SG (1) | SG51992G (da) |
YU (1) | YU47021B (da) |
ZW (1) | ZW8689A1 (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0282132B1 (en) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions and their use for treating gastrointestinal disorders |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009240D0 (en) * | 1990-04-25 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
DK0540613T3 (da) * | 1990-07-20 | 1996-04-01 | Tillotts Pharma Ag | Produkter og fremgangsmåder til behandling af fordøjelseskanalen |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
ES2130152T3 (es) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. |
AU1671295A (en) * | 1994-12-19 | 1996-07-10 | Lauteral Limited | Combinations of ranitidine hydrochloride-form 1 and bismuth compounds |
GB9501560D0 (en) | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
EP0805815B1 (en) * | 1995-01-26 | 2002-04-10 | Nycomed Imaging A/S | Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori |
EP1035192A1 (de) * | 1999-01-26 | 2000-09-13 | Stefan Graichen | Additiv für einen Kühlschmierstoff |
CN1102585C (zh) * | 1999-04-28 | 2003-03-05 | 常州兰陵制药有限公司 | 雷尼替丁枸橼酸铋盐的制备方法 |
US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
CN100402514C (zh) * | 2006-08-01 | 2008-07-16 | 丽珠医药集团股份有限公司 | 一种制备枸橼酸铋雷尼替丁的方法 |
CN101484132A (zh) * | 2007-07-09 | 2009-07-15 | 柏树制药公司 | 具有合意口味的雷尼替丁制剂 |
CN102408398B (zh) * | 2011-09-20 | 2012-12-05 | 江苏汉斯通药业有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
US9731999B2 (en) | 2011-09-23 | 2017-08-15 | Iqbal Gill | Chemical admixtures for hydraulic cements |
ES2426539B1 (es) * | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
CN103896888B (zh) * | 2014-03-28 | 2015-11-18 | 常州兰陵制药有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
WO2015155297A1 (en) | 2014-04-11 | 2015-10-15 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
EP2942058A1 (en) | 2014-05-09 | 2015-11-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists |
CN107382921A (zh) * | 2017-07-28 | 2017-11-24 | 常州兰陵制药有限公司 | 制备枸橼酸铋雷尼替丁的方法 |
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
FR2531706A1 (fr) * | 1982-08-13 | 1984-02-17 | Sanofi Sa | Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant |
BE905235A (fr) * | 1986-08-05 | 1986-12-01 | Hasunor Ag | Ascorbates antagonistes des recepteurs h2 et leur procede de preparation. |
IT1215325B (it) * | 1987-01-07 | 1990-02-08 | Barisintex Sa | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
EP0282132B1 (en) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions and their use for treating gastrointestinal disorders |
DE3710462A1 (de) * | 1987-03-30 | 1988-10-13 | Heumann Pharma Gmbh & Co | Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
-
1989
- 1989-07-14 CH CH2647/89A patent/CH679582A5/fr not_active IP Right Cessation
- 1989-07-17 DK DK351789A patent/DK168381B1/da not_active IP Right Cessation
- 1989-07-17 LU LU88722C patent/LU88722I2/fr unknown
- 1989-07-17 YU YU142789A patent/YU47021B/sh unknown
- 1989-07-17 SE SE8902550A patent/SE468715B/sv not_active IP Right Cessation
- 1989-07-17 CA CA000605843A patent/CA1332610C/en not_active Expired - Fee Related
- 1989-07-17 NL NL8901840A patent/NL192604C/nl not_active IP Right Cessation
- 1989-07-17 MY MYPI89000969A patent/MY104055A/en unknown
- 1989-07-17 AT AT0172889A patent/AT398200B/de not_active IP Right Cessation
- 1989-07-17 IT IT8948196A patent/IT1231481B/it active Protection Beyond IP Right Term
- 1989-07-17 ES ES8902517A patent/ES2014175A6/es not_active Expired - Fee Related
- 1989-07-17 IL IL9100589A patent/IL91005A/en not_active IP Right Cessation
- 1989-07-17 CN CN89104959A patent/CN1022626C/zh not_active Expired - Fee Related
- 1989-07-17 NZ NZ229958A patent/NZ229958A/xx unknown
- 1989-07-17 MX MX1682989A patent/MX174145B/es unknown
- 1989-07-17 US US07/380,378 patent/US5008256A/en not_active Expired - Lifetime
- 1989-07-17 FR FR8909575A patent/FR2634122B1/fr not_active Expired - Fee Related
- 1989-07-17 EG EG34289A patent/EG19368A/xx active
- 1989-07-17 ZW ZW86/89A patent/ZW8689A1/xx unknown
- 1989-07-17 PT PT91188A patent/PT91188B/pt not_active IP Right Cessation
- 1989-07-17 HU HU893595A patent/HU206104B/hu unknown
- 1989-07-17 IE IE230989A patent/IE61076B1/en not_active IP Right Cessation
- 1989-07-17 BE BE8900773A patent/BE1003254A5/fr not_active IP Right Cessation
- 1989-07-17 JP JP1184402A patent/JP2523185B2/ja not_active Expired - Lifetime
- 1989-07-17 LU LU87557A patent/LU87557A1/fr active Protection Beyond IP Right Term
- 1989-07-17 GR GR890100454A patent/GR1000431B/el not_active IP Right Cessation
- 1989-07-17 DE DE3923638A patent/DE3923638C2/de not_active Expired - Fee Related
- 1989-07-17 FI FI893448A patent/FI90538C/fi not_active IP Right Cessation
- 1989-07-17 PL PL28062889A patent/PL162391B1/pl unknown
- 1989-07-17 AU AU38178/89A patent/AU632052B2/en not_active Ceased
- 1989-07-17 NO NO892936A patent/NO176319C/no not_active IP Right Cessation
- 1989-07-17 GB GB8916288A patent/GB2220937B/en not_active Expired - Lifetime
- 1989-07-18 KR KR1019890010213A patent/KR0122598B1/ko not_active IP Right Cessation
-
1992
- 1992-05-09 SG SG519/92A patent/SG51992G/en unknown
- 1992-08-13 HK HK613/92A patent/HK61392A/xx not_active IP Right Cessation
- 1992-12-11 CY CY1650A patent/CY1650A/xx unknown
-
1995
- 1995-06-12 HU HU95P/P00186P patent/HU211173A9/hu unknown
-
1997
- 1997-12-18 NL NL970046C patent/NL970046I2/nl unknown
-
1998
- 1998-02-05 NO NO1998007C patent/NO1998007I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3923638C2 (de) | Salze aus Ranitidin und einem Komplex von Bismut mit einer Carbonsäure, Verfahren zu deren Herstellung und diese Salze enthaltende pharmazeutische Präparate | |
DE68913137T2 (de) | Carbonsäure-Derivate. | |
DE2713389C2 (da) | ||
DE1802394C2 (de) | Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten | |
DE3012862A1 (de) | Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel | |
DE3443065C2 (da) | ||
DE2403122C2 (da) | ||
DE2460929C2 (da) | ||
DE1940566C3 (de) | 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel | |
DE3326724A1 (de) | In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte | |
JPH05117259A (ja) | カルボン酸誘導体 | |
EP0317855A2 (de) | Pharmazeutische Präparate | |
DE2854316A1 (de) | Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum | |
DE69609314T2 (de) | Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung | |
DE2755061A1 (de) | Naphthyridinderivate sowie verfahren zu deren herstellung | |
DE2654185C2 (de) | N-(p-Benzamido)-2-pyrrolidon-4-carbonsäuren und dieselben enthaltende Anti-Ulcusmittel | |
DE2522218C3 (de) | Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung | |
DE3337925C2 (de) | N-(6-Aminopurinyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu dessen Herstellung und seine Verwendung | |
DE3310584C2 (da) | ||
DD291554A5 (de) | Verfahren zur herstellung von salzen eines furanderivates | |
DE2901914C2 (de) | Zinksalz der 6-N-Acetylamino-capronsäure, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel | |
CH618428A5 (da) | ||
RU2114857C1 (ru) | Соли, образованные ранитидином и комплексным соединением висмута с карбоновой кислотой, и фармацевтический препарат | |
EP0061654B1 (de) | Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
DE2839311C2 (de) | Pharmazeutisches Präparat gegen Geschwüre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |